In our report on the prenatal diagnosis in a family with pseudo arylsulfatase A deficiency at risk for metachromatic leukodystrophy (MLD), we indicated that it was our impression that the frequency of the PD allele might be equal to or higher than the frequency of the MLD allele (1). 
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In our report on the prenatal diagnosis in a family with pseudo arylsulfatase A deficiency at risk for metachromatic leukodystrophy (MLD), we indicated that it was our impression that the frequency of the PD allele might be equal to or higher than the frequency of the MLD allele (1). The observations of Zlotogora et al. and our recent involvement in five additional such prenatal diagnosis [one a repeat pregnancy in the index case (I)] have reinforced our view. A svstematic study of the nuances of the present allelism requires kentification &individuals with different genotypes. However, existing enzyme assay techniques do not allow differentiation between the MLD heterozygote and the PD heterozygote, and unequivocal differentiation between the PD homozygote and the MLD-PD mixed heterozygote is problematical. The approach taken by Zlotogora et al., namely studies of parents of known pseudodeficient subjects, will allow the genetic considerations as well as biochemical information tify individuals with different genotypes. In prediction was possible by genetic criteria alone. identification of individuals with the greatly facilitate development of biochemical for population studies.
